Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +111.2% | +112.0% | 3 / 3 | -2.3% | -0.92 pp | +2.43 pp | -2.7% | 0.01 | — | 12,6 | −2,3% | 0,0 | +111,2% | — | 18.79 | — |
| Pts | 12 | 12 | 12 | 0 | 4 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 8.340 (close price on 2026-10-19)EPS (TTM): −430,7
Financial charts
1.Revenue & growth
VND bn12,6Q2/26
1.Revenue & growth
VND bn12,6Q2/26
2.Profit & growth
VND bn0,03Q2/26
3.Profit mix (Penman)
VND bn-3,11Q2/26
4.Margins & cost structure
%6.1%Q2/26
5.Returns & cash cycle
% · days-2.9%Q2/26
6.Earnings quality & cash
VND bn1,40Q2/26
7.Asset structure
VND bn140Q2/26
8.Funding & debt health
VND bn · times140Q2/26
9.Revenue backlog
VND bn0,14Q2/26
10.Valuation
times · %-24,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %4Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
214%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26